Evidence map›Paper›PMID 42124196›Full record

ReviewMaterials (Basel, Switzerland)2026

Biodegradable Metals and Corrosion Control: Challenges, Limits and New Opportunities for Innovating in Orthopedic Fixations.

Abdelhakim Cherqaoui, Carlo Paternoster, Diego Mantovani

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Abdelhakim CherqaouiLaboratory for Biomaterials and Bioengineering, Canada Research Chair Tier I, Department of Mineral, Metallurgical, and Materials Engineering, and University Hospital Research Center, Regenerative Medicine, University Laval, Québec, QC G1L 3L5, Canada.ORCID 0009-0002-5962-0856
Carlo PaternosterLaboratory for Biomaterials and Bioengineering, Canada Research Chair Tier I, Department of Mineral, Metallurgical, and Materials Engineering, and University Hospital Research Center, Regenerative Medicine, University Laval, Québec, QC G1L 3L5, Canada.ORCID 0000-0002-9157-4784
Diego MantovaniLaboratory for Biomaterials and Bioengineering, Canada Research Chair Tier I, Department of Mineral, Metallurgical, and Materials Engineering, and University Hospital Research Center, Regenerative Medicine, University Laval, Québec, QC G1L 3L5, Canada.ORCID 0000-0001-9672-895X

Funding

Natural Science and Engineering Research Council of Canada 2012-2026PRIMA (Quebec Ministry for Economy and Innovation) 2012-2026
6 · The paper itself

Abstract

Biodegradable metals represent a paradigm shift in orthopedic fixation by providing temporary mechanical support synchronized with bone healing while eliminating long-term complications associated with permanent implants. Conventional bioinert alloys, including stainless steels, Ti-based alloys, and Co-Cr alloys, exhibit high elastic moduli that induce stress shielding and often require secondary removal surgeries. In response, resorbable metallic systems based on Mg, Zn, and Fe have emerged as promising alternatives. Among these, Fe-Mn-C alloys stand out for load-bearing applications due to their exceptional strength-ductility balance governed by twinning-induced plasticity mechanisms, tunable degradation behavior, and intrinsic magnetic resonance imaging compatibility through austenitic phase stabilization. Focusing on Fe-Mn-C alloys, this review critically examines the metallurgical design principles underlying stacking fault energy optimization, phase stability, and Mn-controlled electrochemical behavior. Processing innovations, such as additive manufacturing, are discussed as tools to architecture porosity, refine microstructure, and accelerate degradation by graded designs while preserving mechanical structural support during healing. Hybrid metallic-bioactive systems, surface functionalization strategies, and functionally graded porous architectures were evaluated as advanced approaches to enhance osteointegration and modulate degradability. Despite these advances, significant barriers remain for clinical translation. Persistent discrepancies between in vitro and in vivo degradation rates, often attributed to biological encapsulation and degradation product accumulation, complicate lifetime prediction. Localized corrosion at microstructural heterogeneities such as twin boundaries and phase interfaces can undermine structural reliability under load-bearing conditions. Moreover, predictive multi-physics modeling frameworks capable of coupling electrochemical kinetics, mechanical loading, microstructural evolution, and bone remodeling remain underdeveloped, limiting reliable safety-margin estimation. Regulatory progress is further hindered by the absence of standardized testing protocols specifically tailored to Fe-based biodegradable alloys, including harmonized degradation rate windows, validated corrosion-mechanics coupling methodologies, and clinically defined Mn ion release thresholds. This review aims to discuss whether Fe-based alloys, especially Fe-Mn-C alloys, can transition from promising laboratory materials to clinically viable next-generation orthopedic implants capable of delivering patient-specific, mechanically compatible, and biologically synchronized temporary fixation.

Indexed as

biodegradable metalscorrosion controlFe-Mn-C TWIP alloysfixation implantsLPBF

Identifiers

PMID42124196
PMCPMC13164711

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.